ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 718,09
0,11%
Dow Jones
43 487,83
0,78%
DAX
20 912,58
0,07%
Brent Oil
79,615
-0,75%
Bitcoin
108 469,95
5,20%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE

  6. Polemos (PLMO) Cours

Polemos

Polemos (PLMO)

LSE
0,70
0,00
( 0,00% )
Mis à jour : 01:00:00
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
0,70
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
0,00
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Clôture Veille
0,70
Ouverture
-
Dernière Transaction
(O)
Dernière heure de transaction
-
Volume moyen (3 m)
-
Volume financier
-
VWAP
-

PLMO Dernières nouvelles

Plus de nouvelles

Pulmo BioTech Inc. Announces that Its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM) Shows Early Indications of B

NEW YORK, Nov. 11 /PRNewswire-FirstCall/ -- Pulmo BioTech Inc. (OTC Bulletin Board: PLMO.OB; Frankfort Borse: PBO) has announced that early experimental results have indicated that its...

11 Novembre 2009
PR Newswire (US)

Pulmo BioTech Inc. Announces Cash Details of its Previously Announced Letter of Intent Intended to Bring its Pulmonary Vascular

NEW YORK, Oct. 23 /PRNewswire-FirstCall/ -- Pulmo BioTech Inc. (OTC Bulletin Board: PLMO; Frankfort Borse: PBO) has announced that it will ultimately receive at least $3.3 million pursuant to...

23 Octobre 2009
PR Newswire (US)

Pulmo BioTech Inc. Announces Further Details of its Previously Announced Letter of Intent Intended to Bring its Pulmonary Vascul

NEW YORK, Oct. 21 /PRNewswire-FirstCall/ -- Pulmo BioTech Inc. (OTC Bulletin Board: PLMO; Frankfort Borse: PBO) has announced has announced further details of its non-binding letter of intent...

21 Octobre 2009
PR Newswire (US)

Pulmo BioTech Inc. Announces Letter of Intent Regarding Proposed License of its Pulmonary Vascular Diagnostic Product Candidate

NEW YORK, Oct. 20 /PRNewswire-FirstCall/ -- Pulmo BioTech Inc. (OTC Bulletin Board: PLMO; Frankfort Borse: PBO) has announced that it has entered into a non-binding letter of intent with...

20 Octobre 2009
PR Newswire (US)

Pulmo BioTech Inc. Announces Paper to be Presented at Symposium

NEW YORK, May 4 /PRNewswire-FirstCall/ -- Pulmo BioTech Inc. (OTC Bulletin Board: PLMO; Frankfort Borse: PLO) has announced that Dr. Jocelyn Dupuis, the Chief Scientific Officer of its Pulmo...

04 Mai 2009
PR Newswire (US)

Pulmo BioTech Inc. Announces Appointment of Professor John Wallwork as Chairman

NEW YORK, March 17 /PRNewswire-FirstCall/ -- Pulmo BioTech Inc. (OTC Bulletin Board: PLMO) is pleased to announce the appointment of Professor John Wallwork to the Board of the company as...

17 Mars 2009
PR Newswire (US)

Pulmo BioTech Inc. Announces Dual Listing on Frankfurt Borse

NEW YORK, Jan. 12 /PRNewswire-FirstCall/ -- Pulmo BioTech Inc. has completed a dual listing. The Company's shares are now listed on the Frankfurt Borse (symbol PBO) in addition to the OTC BB...

12 Janvier 2009
PR Newswire (US)

Pulmo BioTech Inc. Completes Bio-Distribution Studies

NEW YORK, July 7 /PRNewswire-FirstCall/ -- Pulmo BioTech Inc. (OTC Bulletin Board: PLMO.OB) has announced that its subsidiary, PulmoScience Inc. has completed the bio-distribution studies on its...

07 Juillet 2008
PR Newswire (US)

Pulmo BioTech Announces an Increase in its Stake in PulmoScience

NEW YORK, May 9 /PRNewswire-FirstCall/ -- Pulmo BioTech Inc. (OTC:PLMO) (BULLETIN BOARD: PLMO) announced today that it has increased its stake in PulmoScience Inc. by 10%, taking its total...

09 Mai 2008
PR Newswire (US)

Pulmo BioTech Announces Appointment of Chief Financial Officer

NEW YORK, May 2 /PRNewswire-FirstCall/ -- Pulmo BioTech Inc. (OTC:PLMO) (BULLETIN BOARD: PLMO) announced today that it has appointed Rajiv Garg as it Chief Financial Officer. Pulmo BioTech...

02 Mai 2008
PR Newswire (US)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

PLMO - Frequently Asked Questions (FAQ)

What is the current share price?
The current share price of is 0,70p
What is the 1 year trading range for share price?
has traded in the range of 0,00p to 0,00p during the past year

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
QBTQuantum Blockchain Technologies Plc
2,275p
(40,00%)
133,91M
NTQEnteq Technologies Plc
1,40p
(40,00%)
15,88M
RCHReach Plc
92,10p
(27,92%)
2,57M
STKStreaksai Plc
1,30p
(18,18%)
1,86M
TYMTertiary Minerals Plc
0,0825p
(17,86%)
196,85M
PODPPod Point Group Holdings Plc
10,38p
(-38,18%)
3,1M
PALMPanther Metals Plc
52,50p
(-36,36%)
182,18k
PPSProton Motor Power Systems Plc
0,35p
(-17,65%)
169,95k
SDGSanderson Design Group Plc
45,50p
(-15,74%)
554,5k
PRDPredator Oil & Gas Holdings Plc
6,25p
(-15,54%)
3,1M
NTVONativo Resources Plc
0,0019p
(0,00%)
266,28M
TRPTower Resources Plc
0,032p
(3,23%)
253,56M
TYMTertiary Minerals Plc
0,0825p
(17,86%)
196,85M
PREMPremier African Minerals Limited
0,0265p
(-5,36%)
187,79M
SYMESupply@me Capital Plc
0,0035p
(1,45%)
161,86M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

LSE
PLMO
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés